Zinc and linoleic acid pre-treatment attenuates biochemical and histological changes in the midbrain of rats with rotenone-induced Parkinsonism

• Published in: BMC neuroscience 2018-05, Vol.19 (1), p.29-11, Article 29
• Main Authors: Mbiydzenyuy, Ngala Elvis, Ninsiima, Herbert Izo, Valladares, Miriela Betancourt, Pieme, Constant Anatole
• Format: Article
• Language: English
• Subjects: Ageing; Animals; Antioxidant; Antioxidants - pharmacology; Brain; Care and treatment; Chemical properties; Disease Models, Animal; Female; Gene mutation; Genetic aspects; Glutathione - metabolism; Levodopa - pharmacology; Linoleic acid; Linoleic Acid - pharmacology; Lipid Peroxidation - drug effects; Neuroprotection; Nutrition; Nutritional aspects; Parkinsonian Disorders - chemically induced; Parkinsonian Disorders - drug therapy; Parkinsonism; Physiological aspects; Rats; Rats, Wistar; Rotenone - pharmacology; Zinc (Nutrient); Zinc - pharmacology
• ISSN: 1471-2202; 1471-2202
• DOI: 10.1186/s12868-018-0429-9

Studies have suggested the supplementation of Zinc and Linoleic acid in the management of neurodegenerative disorders but none has investigated the combined effects. Little is known about the neuroprotective effects of either Zinc or Linoleic acid or their combination against development of Parkinsonism. This study was designed to investigate the neuroprotective effects of Zinc and Linoleic acid in rotenone-induced Parkinsonism in rats. Thirty-six young adult female rats weighing 100-150 g divided into six groups were used. Rats were induced with Parkinsonism by subcutaneous administration of rotenone (2.5 mg/kg) once a day for seven consecutive days. The rats received dimethyl sulfoxide (DMSO)/Olive oil or rotenone dissolved in DMSO/Olive oil. Groups III and IV received Zinc (30 mg/kg) or Linoleic acid (150 µl/kg) while group V received a combination of both, 2 weeks prior to rotenone injection. Groups II and VI served as negative (rotenone group) and positive (Levodopa groups) controls respectively. Oxidative stress levels were assessed by estimating Lipid peroxidation (MDA), total antioxidant capacity, Superoxide dismutase, reduced Glutathione (GSH), glutathione peroxidase and catalase in the midbrain. Histological examination was done to assess structural changes in the midbrain. There was a significant prevention in lipid peroxidation and decrease in the antioxidant status in intervention-treated groups as compared to the rotenone treated group. In addition, histological examination revealed that Parkinsonian rat brains exhibited neuronal damage. Cell death and reduction in neuron size induced by rotenone was prevented by treatment with zinc, linoleic acid and their combination. These results suggest that zinc and linoleic acid and their combination showed significant neuroprotective activity most likely due to the antioxidant effect.